Benitec Biopharma Inc. (BNTC) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 44 days, typically, give or take 17 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q1 FY2027Fri, Nov 13, 2026before open 44 8-K
Q4 FY2026Mon, Sep 14, 2026after close 76 8-K
Q3 FY2026Thu, May 14, 2026before open 44 8-K
Q2 FY2026Thu, Feb 12, 2026before open 43 8-K
Q1 FY2026Fri, Nov 14, 2025after close 45 8-K
Q4 FY2025Mon, Sep 22, 2025after close 84 8-K
Q3 FY2025Wed, May 14, 2025before open 44 8-K
Q2 FY2025Fri, Feb 14, 2025before open 45 8-K

What they guided beta

Q1 FY2027 "BB-301 pivotal study design to be finalized in the first calendar quarter of 2027, and the company remains on track to begin the pivotal trial in mid-2027" exhibit
Q1 FY2027 "In this release, operational and program guidance is presented on a calendar-year (CY) basis, and financial guidance is presented on a June 30 fiscal-year (FY) basis HAYWARD, Calif., Nov.13, 2026 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage biotechnology company developing disease-modifying genetic medicines for life-threatening, genetically defined diseases, based on its proprietary “Silence and Replace”" exhibit
Q1 FY2027 "We are grateful to the patients, families and investigators who have enabled this progress, and we look forward to confirming the pivotal study design in the first calendar quarter of 2027, with the study on track to commence in mid-2027.”" exhibit
Q1 FY2027 "In this press release, operational and program guidance is presented on a calendar-year (CY) basis, and historical financial guidance is presented on a June 30 fiscal-year (FY) basis." exhibit
Q4 FY2026 "Interim clinical results for Cohort 1 and Cohort 2 will be presented at the 33rd Annual Congress of the European Society of Gene & Cell Therapy in Hamburg, Germany, October 27-30, 2026 Regulatory Update" exhibit
Q4 FY2026 "Benitec anticipates initiating the BB-301 pivotal trial in mid-2027." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/BNTC
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/BNTC

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

BNTC earnings date badge

HTML

<a href="https://veritasdata.dev/company/BNTC/"><img src="https://veritasdata.dev/embed/BNTC.svg" alt="BNTC earnings date" width="240" height="56"></a>

Markdown

[![BNTC earnings date](https://veritasdata.dev/embed/BNTC.svg)](https://veritasdata.dev/company/BNTC/)

Script

<script async src="https://veritasdata.dev/embed/BNTC.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/BNTC"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.